Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$69.91
-2.11%
Mkt Cap $451.19M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (24 analysts)
$126.00
Range $105.00 – $145.00
Implied Upside
+80.2%
Consensus $126.00 vs current $69.91
NASDAQ·Healthcare·Biotechnology
$69.91
-2.11%
Mkt Cap $451.19M
Buy
6
Hold
1
Sell
0
Price Target (24 analysts)
$126.00
Range $105.00 – $145.00
+80.2%
Consensus $126.00 vs current $69.91